Terminal Sterilization Services Market Is Projected To Reach Approximately USD 19.5 Billion By 2028: Grand View Research Inc.

 Terminal Sterilization Services Market Growth & Trends

The global terminal sterilization services market size is anticipated to reach USD 19.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.3% from 2021 to 2028. The current advent of the novel COVID-19 pandemic has led to the growing demand for sterilization services and is expected to reach new frontiers in the upcoming months. As more and more people are getting infected with COVID, it is likely to create a demand for critical care equipment, which is leading to the growth of the market, globally. This is anticipated to provide plenty of opportunities for market players.

The mounting concerns over healthcare-associated infections spread through the environment or person are the major factor augmenting the market. As per CDC, in the U.S., it was estimated that HAIs account for approximately 1.7 million infections and 99,000 associated deaths each year, thus driving the market.

Growth in the pharmaceutical and biotechnology sector has had a tremendous impact on market growth. According to the Pharmaceutical Research and Manufacturers Association estimates 2018, the U.S.-based biopharmaceutical companies invested nearly USD 102.0 billion in R&D. Thus, increased R&D activities result in increased demand for various sterilization processes in these industries, thereby, fueling market growth during the forecast period.

Furthermore, the introduction of innovative products and the incorporation of new technologies by market players are expected to contribute to market growth during the forecast period. For instance, in April 2020, Matachana Group launched new steam sterilizers-MPHS Series-specifically designed to meet the guidelines of the pharmaceutical industry.

Request a free sample copy or view report summary: Terminal Sterilization Services Market Report

Terminal Sterilization Services Market Report Highlights

• On the basis of product, the ethylene oxide segment dominated the market and accounted for a revenue share of 34.9% in 2020 owing to numerous advantages offered by this method such as simple penetration, large sterilizing volume, and broad material compatibility
• Based on end-use, the pharma segment dominated the market and accounted for a revenue share of 67.0% in 2020. Increasing R&D activities and the launch of complex equipment are boosting demand for the sterilization process in pharmaceutical companies
• North America dominated the market and accounted for a revenue share of 35.6% in 2020 owing to increased adoption of standard sterilization services among hospitals and research centers. Additionally, the constantly expanding patient pool is further driving the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-terminal-sterilization-service-market

Terminal Sterilization Services Market Segmentation

Grand View Research has segmented the global terminal sterilization services market on the basis of product, end-use, and region:

Terminal Sterilization Service Product Outlook (Revenue, USD Million, 2016 - 2028)

• Ethylene Oxide
• Irradiation
• Moist Heat Terminal Sterilization
• Others

Terminal Sterilization Service End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Pharma
• Others

Terminal Sterilization Service Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Terminal Sterilization Services Market

• Steris Plc
• Getinge Group
• Advanced Sterilization Products Services, Inc.
• 3M
• Belimed
• Cantel Medical
• Matachana Group
• Sterigenics International LLC
• Olympus Corp.
• TSO3

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Glassware Market Predicted to Witness Steady Growth During the Forecast Period

 Europe Glassware Market Growth & Trends

The Europe glassware market size is expected to reach USD 4.01 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The market is expected to witness prominent growth in the future owing to the economic growth in emerging countries and the development of attractive glassware products.                              

Furthermore, the increasing urbanization is one of the prominent factors leading to a change in the purchasing behavior of consumers. The growing population due to the migration of individuals from different countries has increased the number of glassware purchases as per the individual’s preference, in turn, propelling the product demand. A majority of the population in each EU-27 Member State lived in owner-occupied dwellings in 2018, this share ranging from 51.4% in Germany to 96.4% in Romania; the EU-27 average was 70.0%. The trend of living in rental houses has resulted in individuals often changing their houses, thus triggering the product demand as individuals prefer new glassware in their new house.

A rise in alcohol consumption is also acting as a major driver for the market from both the residential and commercial sectors. According to a 2019 report by the WHO, on average, adults (aged 15 years and over) in the European Union countries drink the equivalent of more than 2 bottles of wine per week. When lifetime abstainers and former drinkers are removed, it reveals that adults drink more than 3 bottles of wine a week. Across the population, 30.4% of people report having consumed more than 60g of pure alcohol on a single occasion in the last 30 days - this is equivalent to more than 5 drinks on 1 occasion.

The growing trend of nuclear families is creating more opportunities and growth prospects for the market. In addition, the frequency of formal dining occasions at home is increasing, thereby creating more demand for luxury and premium glassware among consumers. However, the use of plastic ware in various small restaurants due to their low cost and less maintenance is projected to restrain the market growth in the commercial sector. However, increasing awareness about the health benefits of using glassware for drinking can negate the effect of the restraining factors.

The growth of the commercial sector, particularly restaurants and cafes, in the region is creating a high demand for glassware. As per the Specialty Coffee Association (SCA), in 2017, there were 301,593 cafes and 13,344 coffee-focused shops in Western Europe. The uptick in the number of café outlets is increasing the need for glassware products, which is likely to boost the growth prospects for the market over the forecast period. In Europe, the U.K. is foreseen to remain at the forefront and is projected to expand at a notable CAGR over the forecast period.

Request a free sample copy or view report summary: Europe Glassware Market Report

Europe Glassware Market Report Highlights

• By product, the wine glass segment is projected to be the fastest-growing segment over the forecast period
• Based on distribution channel, the specialty stores segment dominated the market with a share of over 37.0% in 2020
• In terms of branding, the branded glassware segment is expected to expand at the fastest CAGR of 9.2% from 2021 to 2028
• In Europe, the U.K. held the largest share of almost 16.0% in 2020 and is foreseen to remain at the forefront in the forthcoming years

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-glassware-market-analysis

Europe Glassware Market Segmentation

Grand View Research has segmented the Europe glassware market on the basis of product, distribution channel, branding, and country:

Europe Glassware Product Outlook (Revenue, USD Million, 2016 - 2028)

• Beer Glass
• Wine Glass
• Cocktail Glass
• Spirits Glass
• Others

Europe Glassware Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Supermarkets & Hypermarkets
• Specialty Stores
• Online Retail
• Others

Europe Glassware Branding Outlook (Revenue, USD Million, 2016 - 2028)

• Branded Glassware
• Non-branded Glassware                      

Europe Glassware Country Outlook (Revenue, USD Million, 2016 - 2028)

• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Benelux
  • Russia

List of Key Players of Europe Glassware Market

• Şişecam Glassware
• Villeroy & Boch AG
• Fiskars Group
• Lifetime Brands, Inc.
• Ritzenhoff AG
• Steelite International
• Alessi S.p.A.
• Arc International
• Oertel & Co. Kristallglas
• Bormioli Rocco S.p.A. 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Large Molecule Bioanalytical Technologies Market During 2021 – 2028 to Gain Robust Traction

 Large Molecule Bioanalytical Technologies Market Growth & Trends

The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Request a free sample copy or view report summary: Large Molecule Bioanalytical Technologies Market Report

Large Molecule Bioanalytical Technologies Market Report Highlights

• The product segment accounted for the largest revenue share in 2020
• Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
• Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
• Mass spectrometry captured the maximum revenue share in 2020 due to the diversification of products as well as their frequent usage
• This technology has been conventionally used in the development of protein pharmaceuticals, for instance, in the analysis of confirmations of amino acids in proteins
• Furthermore, quantitative PCR (qPCR) is widely adopted in the detection of viral contaminants during the manufacture of biopharmaceuticals
• Thus, with the growing demand for viral vectors, this technology is anticipated to witness the fastest growth over the forecast period
• Moreover, the presence of a wide array of products in spectrometry is one of the key industry factors driving investment in the segment
• Biologics accounted for the major revenue share in 2020 owing to the ever-expanding R&D activity programs in the segment
• Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services
• The COVID-19 pandemic has accelerated the development of genetic vaccines
• This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment
• North America dominated the market in 2020 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing
• Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region
• In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront
• Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region
• Key companies are focusing on new product launches to sustain their position in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-large-molecule-bioanalytical-technologies-market

Large Molecule Bioanalytical Technologies Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical technologies market on the basis of product & service, technology, application, and region:

Large Molecule Bioanalytical Technologies Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

• Product
  • Consumables & Accessories
  • Instruments
  • Reagents & Kits
• Service

Large Molecule Bioanalytical Technologies Outlook (Revenue, USD Million, 2017 - 2028)

• Electrophoresis
• Chromatography
• Mass Spectrometry
• Western Blot
• ddPCR, qPCR, RT-PCR
• ELISA
• Flow Cytometry
• Spectrometer
  • UV/VIS
  • CD
  • Raman
  • Laser-induced breakdown spectroscopy
  • Other Spectroscopy techniques
• Analytical Ultracentrifugation
• Light scattering (MALS, DLS) & static light scattering
• DNA Sequencing
• Other Technologies

Large Molecule Bioanalytical Technologies Application Outlook (Revenue, USD Million, 2017 - 2028)

• Biologics
  • By Type
    • Monoclonal Antibodies (mAbs)
    • Vaccines
    • Recombinant proteins
  • By Technology
    • Spectrometer
    • Western blot
    • Isoelectric focusing
    • Capillary electrophoresis (CE)
    • Peptide mapping and sequencing by LC-MS/MS
    • Peptide fingerprinting by Chromatography and Mass Spectrometry (MS)
    • ddPCR, qPCR, RT-PCR
    • Others
  • Cell & Nucleic Acid Therapy
    • SDS-PAGE or capillary gel electrophoresis
    • Chromatography
    • Mass Spectrometry/LC-MS
    • UV-Vis Spectrometry
    • ddPCR, qPCR, RT-PCR
    • ELISA Assays
    • Fluorescent Assays
    • Luminescent Assays
    • Western blot
    • Flow Cytometry
    • Others
  • Viral Vector
    • Sanger
    • qPCR, ddPCR, & RTPCR
    • ELISA
    • Electrophoresis
    • NGS
    • Mass Spectrometry
    • Chromatography
    • Dynamic & Static Light Scattering
    • Others
  • Gene Therapy
    • SDS-PAGE or capillary gel electrophoresis
    • Chromatography
    • Mass Spectrometry /LC-MS
    • UV-Vis Spectrometry
    • ddPCR, qPCR, RT-PCR
    • ELISA Assays
    • Fluorescent Assays
    • Luminescent Assays
    • Western blot
    • Flow Cytometry
    • Others
  • Nanoparticles & Polymers
    • Dynamic & static light scattering
    • Laser Diffraction
    • Fluorescence spectrometry
    • Others

Large Molecule Bioanalytical Technologies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in Large Molecule Bioanalytical Technologies Market

• Intertek Group plc.
• Solvias AG
• Bio-Techne Corporation
• Wyatt Technology Corporation
• Precision NanoSystems
• Verder
• Halo Labs
• Charles River Laboratories International, Inc.
• Avomeen
• Merck KGaA
• Cergentis B.V.
• Laboratory Corporation of America Holdings
• SCIEX
• Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mesenchymal Stem Cells Market to Surpass USD 6.1 Billion by 2028: Grand View Research Inc.

 Mesenchymal Stem Cells Market Growth & Trends 

The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been acclaimed effective as a regenerative therapy for skeletal tissue repair and have recently gained traction across modulation of immune cells and endogenous tissues.

Expanding clinical applications of mesenchymal stem cells, strengthening the pipeline of these therapies, along with intensifying market competition are some of the key aspects driving the industry expansion of MSCs. The recent pandemic outbreak of COVID-19 is set to propel the clinical applications and investments done in this market space. For instance, in April 2020, Canada’s The Stem Cell Network (SCN) provided funding of USD 300,000 to the project targeted towards the evaluation of optimal dosage of MSCs, to design an effective therapeutic approach to reduce the impacts of respiratory disorders associated with SARS-CoV-2 infection.

Additionally, as stated by clinicaltrials.gov, 21 clinical trials reportedly incorporated MSCs in the management of COVID-19. Apart from the applications of MSCs in regenerative medicine and tissue engineering, the MSCs serve as a potent therapeutic approach for cancer treatment. As of February 2020, 25 clinical trials have been registered that employ MSCs in the treatment of several cancer indications. This is set to drive the mesenchymal stem cells market (MSCs) market.

Acknowledging the profitable opportunities posed by the market, key industry participants are focused towards initiating technological collaborations to strengthen their market presence. In August 2020, NantKwest Inc. collaborated with Generate Life Sciences Co. to develop a mesenchymal stem cell-based treatment against COVID-19. The latter company is providing with the MSCs derived from donated umbilical cord tissues.

Request a free sample copy or view report summary: Mesenchymal Stem Cells Market Report

Mesenchymal Stem Cells Market Report Highlights

• Widespread use of bone marrow derived MSCs in several therapeutic applications has resulted in the segment’s dominance in 2020
• More than 20.0% of clinical trials incorporate bone marrow MSCs, which is set to maintain the segment’s largest revenue share up to 2028
• The cancer indication segment is expected to witness rapid growth through 2021 to 2028, attributed to the emergence of MSCs as a promising vehicle for anti-cancer drugs
• This is attributed to the tumor tropism ability of MSCs and their ability to manage the predestination of tumor cells
• Disease modelling application generated the highest revenue in 2020, owing to several advantages associated with MSCs such as the high capacity of expansion and self-renewal and reduced tumorigenic capacity, which makes them suitable across disease modelling applications
• The kits, media, and reagents segment held a significant revenue share in 2020 owing to the presence of a substantial number of service providers and increasing demand in the market
• The allogeneic segment dominated the market in 2020; Implantation of allogeneic mesenchymal stem cells serves as a promising tool for cell-based therapy
• As of August 2019, more than 200 clinical trials have been reported for use of allogeneic MSCs, which is expected to propel the segment’s revenue generation capacity from 2021 to 2028
• Apart from the availability of advanced research facilities and skilled professionals, favorable government initiatives and high R&D expenditure, active policies pertaining to cell therapies have contributed to the dominance of North America MSCs market in 2020
• For instance, in August 2020, the Centers for Medicare and Medicaid Services proposed new policies that include cellular therapies, wherein, commercial insurance companies support private health plans associated with MSCs
• The key players are engaged in exploring MSC therapy to its highest potential across different emerging applications, contributing to market growth
• For instance, in July 2020, Promedica presented positive results from its study that evaluated the use of allogeneic MSCs in COVID-19 patients. The study was conducted under the U.S. FDA’s Emergency Investigational New Drug (IND) approval

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mesenchymal-stem-cells-market

Mesenchymal Stem Cells Market Segmentation

Grand View Research has segmented the global mesenchymal stem cells market on the basis of products and services, type, source of isolation, indication, application, and region:

Mesenchymal Stem Cells Products & Services Outlook (Revenue, USD Million, 2017 - 2028)

• Products
  • Workflow Type
    • Cell Sourcing & Isolation
    • Culture & Cryopreservation
    • Differentiation
    • Characterization
  • Product Type
    • Cells & Cell Lines
    • Kits, Media, & Reagents
    • Others
  • Services

Mesenchymal Stem Cells Type Outlook (Revenue, USD Million, 2017 - 2028)

• Autologous
• Allogeneic

Mesenchymal Stem Cells Source of Isolation Outlook (Revenue, USD Million, 2017 - 2028)

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

Mesenchymal Stem Cells Indication Outlook (Revenue, USD Million, 2017 - 2028)

• Bone And Cartilage Repair
• Cardiovascular Disease
• Inflammatory And Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

Mesenchymal Stem Cells Application Outlook (Revenue, USD Million, 2017 - 2028)

• Disease Modelling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Mesenchymal Stem Cells (MSCs) Market

• Thermo Fisher Scientific, Inc.
• Cell Applications, Inc.
• Cyagen Biosciences Inc.
• Axol Biosciences Ltd.
• Cytori Therapeutics Inc
• STEMCELL Technologies Inc
• Celprogen Inc
• BrainStorm Cell Therapeutics Inc.
• Stemedica Cell Technologies Inc
• Merck KGaA (MilliporeSigma)
• Smith+Nephew
• Lonza AG
• PromoCell GmbH
• ScienCell Research Laboratories
• American Type Culture Collection

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Packaged Salad Market Plying for Significant Growth During 2021-2028: Grand View Research Inc.

 Packaged Salad Market Growth & Trends

The global packaged salad market size is expected to reach USD 20.30 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.2% from 2021 to 2028. The growing trend of a healthy lifestyle is one of the key factors that will drive the market over the forecast period. Furthermore, the busy schedules of the millennials leave less time for cooking and various other kitchen chores, and thus people have been demanding ready-to-eat salads.

In recent years, it has been noted that consumers have been opting for vegetables and similar raw ingredients instead of fast foods and processed foods. The increasing focus on weight management owing to rising obesity levels is propelling the demand for packaged salads among consumers around the world. The low caloric content of packaged salads makes them ideal for weight management.

The vegetarian product segment dominated the market with a 67.4% share in 2020. The demand for vegetarian products is significantly growing owing to the rising vegan population around the world. The growing awareness regarding the high carbon footprint of the meat industry, along with animal health and animal cruelty, is compelling an increasing number of consumers to opt for vegetarian products instead.

Organically processed products are expected to expand at the highest CAGR of 8.6% over the forecast period. Organically processed products are generally perceived to contain more nutrients and antioxidants than conventional counterparts. Health-conscious consumers who focus on reducing their exposure to artificial chemicals and antibiotic-resistant bacteria usually prefer organically processed products to conventionally processed alternatives.

Mergers & acquisitions, new product launches, and production capacity expansion are some of the key strategic initiatives taken up by the companies to gain a competitive advantage over other players. In May 2020, Dole Food Company Inc. debuted its DOLE FreshTakes Ready-To-Eat Salad Bowls in the Western U.S. after its successful debut in the Eastern U.S. in 2019.

Request a free sample copy or view report summary: Packaged Salad Market Report

Packaged Salad Market Report Highlights

• The packaged kits type segment is anticipated to register the fastest CAGR of 8.4% from 2021 to 2028. The increasingly hectic lifestyles and rising number of single-person households have been driving the segment
• The online distribution channel is expected to register the fastest CAGR of 9.0% from 2021 to 2028 due to the increasing presence of online retailers
• North America led the market by accounting for more than 41.0% in 2020. The busy lifestyle of the consumers has been propelling the demand for these conveniently packaged salads in the region
• The vegetarian product segment held the largest share of 67.4% in 2020 owning to the growing number of health-conscious consumers across the globe

Access Press Release@ https://www.grandviewresearch.com/press-release/global-packaged-salad-market

Packaged Salad Market Segmentation

Grand View Research has segmented the global packaged salad market on the basis of product, processing, type, distribution channel, and region:

Packaged Salad Product Outlook (Revenue, USD Million, 2016 - 2028)

• Vegetarian
• Non-vegetarian

Packaged Salad Processing Outlook (Revenue, USD Million, 2016 - 2028)

• Organic
• Conventional

Packaged Salad Type Outlook (Revenue, USD Million, 2016 - 2028)

• Packaged Greens
• Packaged Kits

Packaged Salad Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Offline
• Online

Packaged Salad Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Packaged Salad Market

• BrightFarms, Inc.
• Dole Food Company, Inc.
• Earthbound Farm
• Eat Smart (Curation Foods)
• Fresh Express, Incorporated
• Misionero
• Gotham Greens Holdings, LLC
• Mann Packing Co., Inc.
• Bonduelle
• Organicgirl, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurovascular Devices Market Top Companies, Trends and Growth Factors Details for Business Development by 2028

 

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2021 to 2028. Increasing incidence of neurological disorders such as stroke, brain aneurysm, cerebral artery stenosis, are fueling the market growth. For instance, the Stroke Association states, more than 100,000 people suffer from stroke every year in the U.K. Thereby, the numbers reveal the high demand for neurovascular equipment, thus leading to market growth.

Decreased postoperative pain, a speedy recovery is leading to increasing adoption of minimally invasive surgeries and triggering the growth of R&D in this field. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures and is widely recommended by physicians. As compared to the bare-platinum coils, HydroCoils (MicroVention, Tustin, California, USA) has enabled the treatment of more complex aneurysmal structures with lower recurrence rates. Thus, the rising demand for minimally invasive procedures is further fueling the market growth.

Patients suffering from Covid-19 have subsequently exhibited neurologic symptoms that are expected to create a favorable environment for market growth. For instance, as per the study in Lancet, 1 in 3 COVID patients who recovered have neurological and mental health disorders. The study was led by Oxford University researchers and included over 2 lakh COVID patients who recovered from the disease. Such instances will surge the demand for neurovascular equipment. Thus, COVID-19 might have a positive impact on the market in the coming years.

Request a free sample copy or view report summary: Neurovascular Devices Market Report

Neurovascular Devices Market Report Highlights

• The cerebral embolization and aneurysm coiling devices segment dominated the market in 2020 due to soaring incidence of cerebral artery stenosis, increase in the number of technologically advanced product launches by key players and surge in R&D
• Based on therapeutic application, the stroke segment dominated the market in 2020 due to escalating prevalence of stroke globally and the launch of technologically advanced products by the market players
• North America led the market with the maximum revenue share in 2020 owing to the rising prevalence of stroke and brain aneurysm, growing disposable income, and presence of major players in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-neurovascular-devices-market-size-report

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market on the basis of device, therapeutic application, and region:

Neurovascular Device Outlook (Revenue, USD Million, 2016 - 2028)

• Cerebral Embolization and Aneurysm Coiling Devices
  • Embolic coiling
  • Flow Diversion Devices
  • Liquid Embolic agents
• Cerebral Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
• Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares
• Support Devices
  • Micro Catheters
  • Micro Guidewires

Neurovascular Device Therapeutic Application Outlook (Revenue, USD Million, 2016 - 2028)

• Stroke
• Cerebral Artery Stenosis
• Cerebral Aneurysm
  • Aneurysmal Subarachnoid Hemorrhage
  • Others
• Others

Neurovascular Device Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Neurovascular Devices Market

• Medtronic
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Stryker Corporation
• Johnson & Johnson Services, Inc.
• MicroVention, Inc.
• Codman Neuro

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Track and Trace Solutions Market is Expected to Grow at a CAGR of 19.0% during the Forecast Period: Grand View Research Inc.

 

Track And Trace Solutions Market Growth & Trends

The global track and trace solutions market size is expected to reach USD 9.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.0% from 2021 to 2028. The growth is attributed majorly due to the increasing focus of pharmaceutical and biopharmaceutical companies on ensuring brand protection from counterfeit products and theft. The deployment of a track and trace system helps manufacturers enhance distribution channel efficiency and reduces the frequency of counterfeit products.

Furthermore, the rising adoption of track and trace systems by healthcare manufacturers would fuel the market growth in the long run. The introduction of advanced technology, such as RFID, provides fast reading and delivers high levels of security. However, the deployment cost of serialization and aggregation methods, as well as the lack of common regulations and standards, may hamper the market growth in few developing geographies.

US CBP and customs of other member countries as well as by the World Customs Organization reported the seizures of false coronavirus tests and personal protective equipment for example facemasks and hand sanitizers. For instance, in May 2020, Smartrac teamed up with SUKU to validate COVID-19 testing kits and personal protective equipment to permit prompt verification and deliver end-to-end supply chain transparency. Hence, it is estimated that the market will witness lucrative growth opportunities due to the COVID-19 outbreak.

Request a free sample copy or view report summary: Track And Trace Solutions Market Report

Track And Trace Solutions Market Report Highlights

• The software solution was the largest revenue-generating segment of the market in 2020. This contribution is mainly because of the regulatory mandates for the execution of serialization and aggregation in the healthcare sector
• The serialization solution was the largest grossing segment in 2020. Increasing application of serialization in pharmaceuticals and medical devices packaging will be a vital factor contributing to the growth of the segment
• The RFID segment is expected to exhibit the fastest growth rate during the study period. The key factors attributing to the growth of the segment are technological advantages, such as high durability and reusability, more data storage capacity, and no requirement of the line of sight
• North America dominated the market in 2020. The rising implementation of regulatory standards and regulations along with the high adoption rate of track and trace systems by consumers is anticipated to contribute to the growth of the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-track-trace-solutions-market

Track And Trace Solutions Market Segmentation

Grand View Research has segmented the global track and trace solutions market on the basis of product, technology, application, end-use, and region:

Track & Trace Solution Product Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware Systems
  • Printing & marking
  • Monitoring & verification
  • Labeling
  • Others
• Software Solutions
  • Plant manager software
  • Line controller software
  • Bundle tracking software
  • Others

Track & Trace Solution Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Barcodes
• RFID

Track & Trace Solution Application Outlook (Revenue, USD Million, 2016 - 2028)

• Serialization Solutions
  • Bottle Serialization
  • Label Serialization
  • Carton Serialization
  • Data Matrix Serialization
• Aggregation Solutions
  • Bundle Aggregation
  • Case Aggregation
  • Pallet Aggregation

Track & Trace Solution End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical & biopharmaceutical Companies    
• Medical Device Companies   
• Healthcare Others
• Food and Beverage
• Consumer Goods
• Luxury Goods

Track & Trace Solution Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Switzerland
  • Belgium
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Egypt

List of Key Players of Track And Trace Solutions Market

• Axway
• Mettler-Toledo International, Inc.
• Optel Vision
• TraceLink, Inc.
• Adents International
• Antares Vision srl
• Siemens AG
• Seidenader Maschinenbau GmbH
• ACG Worldwide
• Systech, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Companion Animal Health Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Companion Animal Health Market Growth & Trends

The global companion animal health market size is anticipated to reach USD 37.49 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.2% from 2021 to 2028. Growing pet adoption, rising cases of acute & chronic health conditions in pets, and availability of pet insurance are the factors responsible for the growth of this market.

Growing investments and strategic initiatives by market players to develop advanced solutions for pet care is another key contributor to the growth of the market. For instance, in February 2020, Boehringer Ingelheim received approval for Aservo Equihaler, which is its first therapy for severe equine asthma.

Furthermore, the rising adoption of pet insurance is anticipated to fuel the market growth. As per The Holland Insurance Company Pty. Ltd., 20% of GenY and 12% of baby boomer pet owners have pet insurances in Australia. The pet insurance industry is also growing steadily in countries, such as India. These factors, combined with the humanization of pets and increasing pet health concerns, are expected to increase the demand for pet health products and services.

The market was impacted by the Covid-19 pandemic. Market participants had to face several challenges, such as demand slowdown, supply chain disruptions, and operational hurdles, due to the changing norms and restrictions. The pandemic created working capital pressures across the commercial value chain. However, the growing attachment of pet owners to their pets during this pandemic resulted in increased spending on pet healthcare. This has positively impacted the industry development.

The market is highly competitive and companies are undertaking various business strategies to sustain the heavy competition. As per its March 2020 press release, Ceva, a French global veterinary health company, focused on its inventory planning to ensure continuous product availability during the pandemic. The pre-availability of several months of safety stocks of the company’s strategic vaccines and pharmaceutical products created an added buffer to combat any supply chain interruptions.

Request a free sample copy or view report summary: Companion Animal Health Market Report

Companion Animal Health Market Report Highlights

• The pharmaceuticals product segment held the largest revenue share in 2020. Ongoing advancements and research in drug formulations is the key growth-driving factor for the segment
• The diagnostics segment is expected to grow at an exponential rate owing to increasing cases of zoonotic infections, which is likely to boost the need for the establishment of diagnostic laboratories and Point-of-Care (PoC) testing
• The veterinary hospitals & clinics end-use segment accounted for the largest share in 2020
• This growth can be credited to an increasing number of hospitals and clinics and the availability of a wide range of treatments and diagnostic options for pets in these healthcare settings
• North America led the market in 2020 owing to the presence of major players and increasing prevalence of acute & chronic diseases in pets
• Asia Pacific is expected to be the fastest-growing regional market during the forecast period due to rising pet ownership and pet health concerns

Access Press Release@ https://www.grandviewresearch.com/press-release/global-companion-animal-health-market

Companion Animal Health Market Segmentation

Grand View Research has segmented the global companion animal health market on the basis of animal type, product, distribution channel, end-use, and region:

Companion Animal Health Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Dogs
• Equine
• Cats
• Others

Companion Animal Health Product Outlook (Revenue, USD Million, 2016 - 2028)

• Vaccines
• Pharmaceuticals
  • OTC
  • Prescription
• Feed Additives
• Diagnostics
• Others

Companion Animal Health Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Retail
• E-commerce
• Hospital Pharmacies

Companion Animal Health End-use Outlook (Revenue, USD Million, 2016 - 2028)

• PoC/In-house Testing
• Veterinary Hospitals & Clinics
• Others

Companion Animal Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Malaysia
  • Singapore
  • Thailand
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • UAE
  • Israel

List of Key Players of Companion Animal Health Market

• Merck & Co., Inc.
• Ceva
• Vetoquinol S.A.
• Zoetis
• Boehringer Ingelheim International GmbH
• Elanco
• Virbac
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd.
• Agrolabo S.p.A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personalized Retail Nutrition & Wellness Market to Raise at CAGR of 7.9% from 2021 to 2028: Grand View Research Inc.

 

Personalized Retail Nutrition And Wellness Market Growth & Trends

The global personalized retail nutrition and wellness market size is expected to reach USD 3.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The market growth can be attributed to the factors such as driving nutrition strategies, growing focus on nutrigenomics and nutrigenetics, a shift in the healthcare paradigm, and integration of data science for the development of innovative personalized nutrition.

In addition, nutrigenomics is gaining momentum owing to the rising number of studies for understanding the interrelation of nutrients with an individual’s genetic make-up. For instance, in May 2020, researchers revealed the role of flavonol intake in cardiometabolic diseases with the application of systematic bioinformatics analysis. The analysis revealed genes that are involved in leukocyte adhesion, lipid metabolism, and transendothelial migration. In addition, the study also analyzed the nutrigenomic effects of the compound in intestinal cells and their role in the metabolism of circulating lipoproteins.

Moreover, the companies operating in the market for personalized retail nutrition and wellness are heavily investing in bringing innovative solutions for sufficing nutritional diet in individuals, which is further contributing to market growth. Companies are investing in enhancing technologies that can help in the development of new product lines related to microbiota, nutrition, and digital health.

For instance, in November 2020, ADM Ventures announced its investment in Seventure’s Health For Life Capital (HFLC) Fund II. The company works with the Seventure team for identifying opportunities with the application of microbiome solutions for developing dietary supplements and other food and beverage applications. Hence, companies are extensively discovering and leveraging new nutritional ingredients for treating chronic diseases and common ailments.

Furthermore, the COVID-19 pandemic has a positive impact on the growth of the market for personalized retail nutrition and wellness. The demand for vitamins, minerals, and supplements is growing at an exponential rate owing to its potential role in the management of COVID-19. Several vitamins and minerals such as vitamins C, vitamin D, and zinc, have immunomodulatory functions and have a vital role in preserving physical tissue barriers. Hence, the demand for such nutrients for optimizing the immune system to prevent or lower the risk of COVID-19 infection is further contributing to the growth of the market for personalized retail nutrition and wellness. 

Request a free sample copy or view report summary: Personalized Retail Nutrition And Wellness Market Report

Personalized Retail Nutrition And Wellness Market Report Highlights

• The repeat recommendation segment accounted for the largest revenue share in 2020 owing to the rising launch of commercial apps for monitoring an individual’s lifestyle and health
• In the repeat recommendation segment, the functional foods segment dominated the market in 2020 owing to the high adoption of commercially available products for analyzing lifestyle patterns of the patients
• The orthopedics, musculoskeletal, and spine segment held a substantial market share in 2020 due to the high demand for nutrient-based recommendations for the management or prevention of chronic diseases such as cardiovascular disease, obesity, and diabetes
• In the fixed recommendation segment, the dietary supplements and nutraceuticals segment is expected to witness lucrative growth owing to the growing incidence of lifestyle-based diseases
• North America held the largest revenue share in 2020. Growth in this region is owing to the presence of key players and extensive R&D activities
• In Asia Pacific, the market is expected to witness significant growth over the forecast period owing to the reducing sequencing price and nutrigenomic testing, making it more accessible to population across the region
• Companies operating in the market are launching new personalized nutrition products. For instance, in April 2020, Nestlé launched NESQINO, a personalized healthy drink series made from 100 percent natural ingredients

Access Press Release@ https://www.grandviewresearch.com/press-release/global-personalized-retail-nutrition-wellness-market

Personalized Retail Nutrition And Wellness Market Segmentation

Grand View Research has segmented the global personalized retail nutrition and wellness market based on recommendation and region:

Personalized Retail Nutrition & Wellness Recommendation Outlook (Revenue, USD Million, 2017 - 2028)

• Fixed Recommendation
  • Dietary Supplements & Nutraceuticals
    • Vitamins
    • Proteins
    • Minerals
    • Amino Acids
    • Enzymes
    • Other dietary supplements & nutraceuticals
  • Functional Foods
    • Proteins
    • Vitamins
    • Dietary Fibers
    • Fatty Acids
    • Minerals
    • Prebiotics & Probiotics
    • Carotenoids
  • Traditional Botanicals
• Repeat Recommendation
  • Dietary Supplements & Nutraceuticals
    • Vitamins
    • Proteins
    • Minerals
    • Amino Acids
    • Enzymes
    • Other dietary supplements & nutraceuticals
  • Functional Foods
    • Proteins
    • Vitamins
    • Dietary Fibers
    • Fatty Acids
    • Minerals
    • Prebiotics & Probiotics
    • Carotenoids
  • Traditional Botanicals
• Continuous Recommendation
  • Dietary Supplements & Nutraceuticals
    • Vitamins
    • Proteins
    • Minerals
    • Amino Acids
    • Enzymes
    • Other dietary supplements & nutraceuticals
  • Functional Foods
    • Proteins
    • Vitamins
    • Dietary Fibers
    • Fatty Acids
    • Minerals
    • Prebiotics & Probiotics
    • Carotenoids
  • Traditional Botanicals

Personalized Retail Nutrition & Wellness Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • Spain
  • Italy
  • Switzerland
  • UK.
  • Russia
  • Poland
  • Hungary
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Ecuador
• Middle East & Africa
  • Saudi Arabia
  • Iran
  • South Africa
  • Turkey

List of Key Players of Personalized Retail Nutrition And Wellness Market

• The Nature’s Bounty Co.
• Bayer AG
• PlateJoy
• Better Therapeutics, Inc
• Tracxn Technologies
• Viome (Habit Food Personalized, LLC)
• BitBite Inc.
• Noom, Inc.
• Savor Health
• Foodsmart, Inc.
• GLUCOVATION, INC.
• Healbe
• AIRO Health Care (Pty) Ltd.
• Nutrigenomix
• DNAfit
• BiogeniQ Inc.
• Vitagene
• Consumer Physics
• Pfizer, Inc.
• GlaxoSmithKline plc
• Herbalife International of America, Inc.
• Reckitt Benckiser Group PLC.
• DowDuPont
• Tellspec
• Cargill, Incorporated

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.